Original Research
Published on 28 Feb 2020
GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00241
- 6,770 views
- 19 citations




